Probiotic Supplementation Among Adults With Recurrent Gastrointestinal Symptoms
A Randomized Controlled Trial of a Commercially-Available Probiotic Supplement (Trenev Trio®/Healthy Trinity®) and the Promotion of Normal Gastrointestinal Function Among Adults With Recurrent Gastrointestinal Symptoms
Sponsor: University of Maryland, Baltimore
Listed as NCT02277431, this PHASE2/PHASE3 trial focuses on Abdominal Pain and Bloating and remains completed. Sponsored by University of Maryland, Baltimore, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Oct 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jan 2021 — Oct 2021 [monthly]
Completed PHASE2_PHASE3
-
Sep 2019 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Sep 2019 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
First recorded
Dec 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Maryland, Baltimore
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.